Prescription drug · ANDA
Hydrochlorothiazide NDC 82804-973
Hydrochlorothiazide 50 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82804-973-00 | 82804097300 | 100 TABLET in 1 BOTTLE (82804-973-00)Marketed from Feb 13, 2025 | |
| 82804-973-11 | 82804097311 | 1000 TABLET in 1 BOTTLE (82804-973-11)Marketed from Feb 13, 2025 | |
| 82804-973-30 | 82804097330 | 30 TABLET in 1 BOTTLE (82804-973-30)Marketed from Feb 13, 2025 | |
| 82804-973-55 | 82804097355 | 500 TABLET in 1 BOTTLE (82804-973-55)Marketed from Feb 13, 2025 | |
| 82804-973-60 | 82804097360 | 60 TABLET in 1 BOTTLE (82804-973-60)Marketed from Feb 13, 2025 | |
| 82804-973-72 | 82804097372 | 120 TABLET in 1 BOTTLE (82804-973-72)Marketed from Feb 13, 2025 | |
| 82804-973-90 | 82804097390 | 90 TABLET in 1 BOTTLE (82804-973-90)Marketed from Feb 13, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hydrochlorothiazide
- Generic name (nonproprietary)
- hydrochlorothiazide
- Active ingredients
- Hydrochlorothiazide — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 087068
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
- Identifiers
- Product ID 82804-973_4c1a2fb9-133d-4bd5-a336-e47d54f22c97SPL ID 4c1a2fb9-133d-4bd5-a336-e47d54f22c97SPL set ID 4c1a2fb9-133d-4bd5-a336-e47d54f22c97RxCUI 197770, 310798UNII 0J48LPH2THUPC 0382804973309, 0382804972302
- Pharmacologic class
- Thiazide Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482804097300followed by a unit qualifier and the quantityPackage 82804-0973-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide has also been found useful in edema due to various forms of renal dysfunction such as the nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 087068
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | Oxford Pharmaceuticals, LLC | 69584-362 |
| Hydrochlorothiazide | Hydrochlorothiazide 50 mg/1 | TabletOral | A-S Medication Solutions | 50090-6156 |